Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.48 |
| ▸ | CA12 | O43570 | 2/20 | 0.48 |
| ▸ | CA7 | P43166 | 2/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.48 |
| ▸ | ADH1B | P00325 | 1/20 | 0.48 |
| ▸ | ADH1C | P00326 | 1/20 | 0.48 |
| ▸ | ADH1A | P07327 | 1/20 | 0.48 |
| ▸ | ADH7 | P40394 | 1/20 | 0.48 |
| ▸ | IDO1 | P14902 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.45 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15840092 | 0.76 | SMN1; SMN2 (0.46) | CA2CA12IDO1MEN1KMT2A | |
| SCHEMBL27827507 | 0.76 | CA2 (0.45) | CA2CA12CA7CA14ADH1B | |
| SCHEMBL15876410 | 0.76 | TGM2 (0.44) | CA2CA12MEN1KMT2AMAPT | |
| SCHEMBL15418809 | 0.76 | MEN1 (0.52) | IDO1MEN1KMT2AALDH1A1HPGD | |
| SCHEMBL19991861 | 0.76 | — | — | |
| SCHEMBL17434647 | 0.76 | SIGMAR1 (0.54) | CA2CA12IDO1MEN1KMT2A | |
| SCHEMBL13777371 | 0.76 | LMNA (0.52) | IDO1KMT2AALDH1A1HPGDTP53 | |
| SCHEMBL27698277 | 0.76 | KMT2A (0.58) | MEN1KMT2AHSD17B10ALDH1A1HPGD | |
| SCHEMBL16090747 | 0.76 | CA2 (0.52) | CA2MEN1KMT2ATDP1MAPT | |
| SCHEMBL17103657 | 0.74 | CHRM2 (0.53) | IDO1CYP3A4TP53CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119798210-B | Preparation method of high-purity glycolide | 山东金特安全科技有限公司 | 2025-05-20 | — | — | CN | claimed |
| CN-119798210-A | Preparation method of high-purity glycolide | 山东金特安全科技有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-119315103-A | Rechargeable magnesium battery electrolyte and preparation method thereof | 东北大学秦皇岛分校 | 2025-01-14 | — | — | CN | claimed |
| US-20230266302-A1 | SYNTHESIS AND USE OF N-BENZYL SULFONAMIDES | THE UNIV OF TULSA (US) | 2023-08-24 | — | — | US | claimed |
| EP-4185706-A1 | SYNTHESIS AND USE OF N-BENZYL SULFONAMIDES | The University Of Tulsa (US) | 2023-05-31 | — | — | EP | claimed |
| CN-113527152-A | Biphenylsulfonamide compound and method for preventing and treating crop pests by using same | 西北农林科技大学 | 2021-10-22 | — | — | CN | claimed |
| CN-110963967-B | Preparation method of 2-methyl-4-aminoquinoline | 武汉智顿科技发展有限公司 | 2021-02-12 | — | — | CN | claimed |
| CN-110963967-A | Preparation method of 2-methyl-4-aminoquinoline | 武汉智顿科技发展有限公司 | 2020-04-07 | — | — | CN | claimed |
| CN-119798210-B | Preparation method of high-purity glycolide | 山东金特安全科技有限公司 | 2025-05-20 | — | — | CN | disclosed |
| CN-119798210-A | Preparation method of high-purity glycolide | 山东金特安全科技有限公司 | 2025-04-11 | — | — | CN | disclosed |
| US-20250093329-A1 | SCREENING OF COMPOUNDS | THE UNIVERSITY OF TULSA | 2025-03-20 | — | — | US | disclosed |
| CN-112494657-B | Sulfonamide linkers, conjugates thereof and methods of making | 西纳福克斯股份有限公司 | 2025-02-11 | — | — | CN | disclosed |
| CN-119315103-A | Rechargeable magnesium battery electrolyte and preparation method thereof | 东北大学秦皇岛分校 | 2025-01-14 | — | — | CN | disclosed |
| EP-4469592-A1 | SCREENING OF COMPOUNDS | The University Of Tulsa (US) | 2024-12-04 | — | — | EP | disclosed |
| US-20090170861-A1 | Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors | SCHERING CORPORATION AND ALBANY MOLECULAR RESEARCH, INC. | 2009-07-02 | — | — | US | disclosed |
| US-20090170861-A1 | Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors | SCHERING CORPORATION AND ALBANY MOLECULAR RESEARCH, INC. | 2009-07-02 | — | — | US | disclosed |
| WO-2009017671-A1 | SYNTHESIS OF INHIBITORS OF 11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 | VITAE PHARMACEUTICALS, INC. (US) | 2009-02-05 | — | — | WO | disclosed |
| US-7459455-B2 | Pyrimidine compounds | SMITHKLINE BEECHAM CORPORATION (US) | 2008-12-02 | — | — | US | disclosed |
| CN-1026048-C | Use of solsonylurea compounds as herbicide | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1994-10-05 | — | — | CN | disclosed |
| CN-1059073-A | Solsonylurea compounds is as the purposes of weed killer herbicide | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1992-03-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090170861-A1 | Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors | MAN2A1, GYS2, MANBA | CA2 3206/4885CA12 4603/4885CA7 3760/4885 |
| US-20230266302-A1 | SYNTHESIS AND USE OF N-BENZYL SULFONAMIDES | ATP5ME, ATP5F1B, ATP5MG | CA2 2378/4885CA12 3134/4885CA7 2170/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.